Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing
MT newswire2026/10/05 21:4605:46 PM EDT, 10/05/2026 (MT Newswires) -- Christopher M Starr, Director, on October 01, 2026, sold 8,400 shares in Monopar Therapeutics (MNPR) for $659,387. Following the Form 4 filing with the SEC, Starr has control over a total of 15,053 common shares of the company, with 5,173 shares held directly and 9,880 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1645469/000143774926032048/xslF345X05/rdgdoc.xml
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
